Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Neeru Kaushik, Michael J. Eckrich, David Parra & Elizabeth Yang. (2012) Chronically Transfused Pediatric Sickle Cell Patients are Protected from Cardiac Iron Overload. Pediatric Hematology and Oncology 29:3, pages 254-260.
Read now
Read now
Khaled M. Musallam & Ali T. Taher. (2011) Iron Chelation Therapy for Transfusional Iron Overload: A Swift Evolution. Hemoglobin 35:5-6, pages 565-573.
Read now
Read now
Articles from other publishers (53)
Phaosin Thongsaen, Pantipa Tonsawan, Chinadol Wanitpongpun, Theerin Lanamtieng, Pisa Phiphitaporn & Nattiya Teawtrakul. (2023) Clinical features and risk factors of renal dysfunctions in thalassemic patients. International Urology and Nephrology 55:7, pages 1779-1785.
Crossref
Crossref
Selami Kaban & Çağrı Damar. (2021)
Interrelationship between liver
T2
*‐weighted magnetic resonance imaging and acoustic radiation force impulse elastography measurement results and plasma ferritin levels in children with
β‐thalassemia
major
. Journal of Clinical Ultrasound 50:1, pages 108-116.
Crossref
Crossref
Cecilia H. Kim & Heather A. Leitch. (2021) Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae. Critical Reviews in Oncology/Hematology 163, pages 103367.
Crossref
Crossref
Evi Dewiyanti, Aditiawati Aditiawati & Dian Puspita Sari. (2021) Serum ferritin levels and endocrine disorders in children with thalassemia major. Paediatrica Indonesiana 61:3, pages 125-32.
Crossref
Crossref
Michael Liu, Rami Vanguri, Simukayi Mutasa, Richard Ha, Yu-Cheng Liu, Terry Button & Sachin Jambawalikar. (2020) Channel width optimized neural networks for liver and vessel segmentation in liver iron quantification. Computers in Biology and Medicine 122, pages 103798.
Crossref
Crossref
Azadeh Goodarzi, Elham Behrangi, Afsaneh Sadeghzadeh Bazargan, Masoomeh Rohaninasab, Fatemeh Sadat Hosseini-Baharanchi, Mahsa Shemshadi & Elham Vafaei. (2020) The association between melasma and iron profile: a case-control study. Russian Open Medical Journal 9:2.
Crossref
Crossref
Chin Fang Ngim, Nai Ming Lai, Janet YH Hong, Shir Ley Tan, Amutha Ramadas, Premala Muthukumarasamy & Meow-Keong Thong. (2020) Growth hormone therapy for people with thalassaemia. Cochrane Database of Systematic Reviews 2020:5.
Crossref
Crossref
Ambra Di Veroli, Alessia Campagna, Marianna De Muro, Luca Maurillo, Malgorzata Monika Trawinska, Sabrina LeonettiCrescenzi, Luca Petriccione, Atelda Romano, Ada D’Addosio, Antonia Cenfra, Marco Montanaro, Stefano Felici, Alessandro Andriani, Ida Carmosino, Pasquale Niscola, Enrico Montefusco, Massimo Breccia & Roberto Latagliata. (2019) Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?. Leukemia Research 76, pages 65-69.
Crossref
Crossref
Nour M. Moukalled, Fuad A. El Rassi, Sally N. Temraz & Ali T. Taher. (2018) Iron overload in patients with myelodysplastic syndromes: An updated overview. Cancer 124:20, pages 3979-3989.
Crossref
Crossref
Sahar M. El-Haggar, Mohamed R. El-Shanshory, Rasha A. El-shafey & Mohamed S. Dabour. (2018) Decreasing cardiac iron overload with Amlodipine and Spirulina in children with β-thalassemia. Pediatric Hematology Oncology Journal 3:3, pages 64-69.
Crossref
Crossref
Xing Lu, Yajun Ma, Eric Y. Chang, Qun He, Adam Searleman, Annette Drygalski & Jiang Du. (2018) Simultaneous quantitative susceptibility mapping (QSM) and for high iron concentration quantification with 3D ultrashort echo time sequences: An echo dependence study. Magnetic Resonance in Medicine 79:4, pages 2315-2322.
Crossref
Crossref
Pairash Saiviroonporn, Pornpim Korpraphong, Vip Viprakasit & Rungroj Krittayaphong. (2018) An Automated Segmentation of R2* Iron-Overloaded Liver Images Using a Fuzzy C-Mean Clustering Scheme. Journal of Computer Assisted Tomography 42:3, pages 387-398.
Crossref
Crossref
Axel J. Krafft, Ralf B. Loeffler, Ruitian Song, Aaryani Tipirneni-Sajja, M. Beth McCarville, Matthew D. Robson, Jane S. Hankins & Claudia M. Hillenbrand. (2017) Quantitative ultrashort echo time imaging for assessment of massive iron overload at 1.5 and 3 Tesla. Magnetic Resonance in Medicine 78:5, pages 1839-1851.
Crossref
Crossref
Chin Fang Ngim, Nai Ming Lai, Janet YH Hong, Shir Ley Tan, Amutha Ramadas, Premala Muthukumarasamy & Meow-Keong Thong. (2017) Growth hormone therapy for people with thalassaemia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Aaryani Tipirneni-SajjaAxel J. KrafftM. Beth McCarvilleRalf B. LoefflerRuitian SongJane S. HankinsClaudia M. Hillenbrand. (2017) Radial Ultrashort TE Imaging Removes the Need for Breath-Holding in Hepatic Iron Overload Quantification by R2* MRI. American Journal of Roentgenology 209:1, pages 187-194.
Crossref
Crossref
Wen Hong, Qun He, Shujuan Fan, Michael Carl, Hongda Shao, Jun Chen, Eric Y Chang & Jiang Du. (2017) Imaging and quantification of iron-oxide nanoparticles (IONP) using MP-RAGE and UTE based sequences. Magnetic Resonance in Medicine 78:1, pages 226-232.
Crossref
Crossref
Vipul R. Sheth, Shujuan Fan, Qun He, Yajun Ma, Jacopo Annese, Robert Switzer, Jody Corey-Bloom, Graeme M. Bydder & Jiang Du. (2017) Inversion recovery ultrashort echo time magnetic resonance imaging: A method for simultaneous direct detection of myelin and high signal demonstration of iron deposition in the brain – A feasibility study. Magnetic Resonance Imaging 38, pages 87-94.
Crossref
Crossref
Dong-Mei Zou & Wan-Ling Sun. (2017) Relationship between Hepatitis C Virus Infection and Iron Overload. Chinese Medical Journal 130:7, pages 866-871.
Crossref
Crossref
Ralf B. Loeffler, M. Beth McCarville, Anne W. Wagstaff, Matthew P. Smeltzer, Axel J. Krafft, Ruitian Song, Jane S. Hankins & Claudia M. Hillenbrand. (2016) Can multi-slice or navigator-gated R2* MRI replace single-slice breath-hold acquisition for hepatic iron quantification?. Pediatric Radiology 47:1, pages 46-54.
Crossref
Crossref
Satoshi Ito, Katsuya Ikuta, Daisuke Kato, Addo Lynda, Kotoe Shibusa, Noriyasu Niizeki, Yasumichi Toki, Mayumi Hatayama, Masayo Yamamoto, Motohiro Shindo, Naomi Iizuka, Yutaka Kohgo & Mikihiro Fujiya. (2016) In vivo behavior of NTBI revealed by automated quantification system. International Journal of Hematology 104:2, pages 175-181.
Crossref
Crossref
Axel J. Krafft, Ralf B. Loeffler, Ruitian Song, Xiao Bian, M. Beth McCarville, Jane S. Hankins & Claudia M. Hillenbrand. (2016) Does fat suppression via chemically selective saturation affect R2*-MRI for transfusional iron overload assessment? A clinical evaluation at 1.5T and 3T. Magnetic Resonance in Medicine 76:2, pages 591-601.
Crossref
Crossref
Chin Fang Ngim, Nai Ming Lai, Janet Y Hong, Shir Ley Tan, Amutha Ramadas, Premala Muthukumarasamy & Meow-Keong Thong. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Charles T. Quinn & Tim G. St Pierre. (2016) MRI Measurements of Iron Load in Transfusion-Dependent Patients: Implementation, Challenges, and Pitfalls. Pediatric Blood & Cancer 63:5, pages 773-780.
Crossref
Crossref
Claire Sheeran, Donald K. Bowden, Sant-Rayn Pasricha, Ken Cheng, Giovanni Romanelli & Roger E. Peverill. (2016) Benign Cardiac Effects of Hemoglobin H Disease. Acta Haematologica 135:4, pages 200-207.
Crossref
Crossref
Pairash Saiviroonporn, Vip Viprakasit & Rungroj Krittayaphong. (2015) Improved R2* liver iron concentration assessment using a novel fuzzy c-mean clustering scheme. BMC Medical Imaging 15:1.
Crossref
Crossref
Concetta Fragomeno, Emilio Roccabruna & Domenico Giuseppe D'Ascola. (2015) Effect of deferasirox on iron overload in patients with transfusion-dependent haemoglobinopathies. Blood Cells, Molecules, and Diseases 55:4, pages 382-386.
Crossref
Crossref
Sidharth Totadri, Deepak Bansal, Prateek Bhatia, Savita V. Attri, Amita Trehan & R. K. Marwaha. (2015) The deferiprone and deferasirox combination is efficacious in iron overloaded patients with β-thalassemia major: A prospective, single center, open-label study. Pediatric Blood & Cancer 62:9, pages 1592-1596.
Crossref
Crossref
Qian Zheng, Yanqiu Feng, Xiaping Wei, Meiyan Feng, Wufan Chen, Zhentai Lu, Yikai Xu, Hongwen Chen & Taigang He. (2015) Automated interventricular septum segmentation for black-blood myocardial T2* measurement in thalassemia. Journal of Magnetic Resonance Imaging 41:5, pages 1242-1250.
Crossref
Crossref
Niraj ShenoyNishanth VallumsetlaEliezer Rachmilewitz, Amit VermaYelena Ginzburg. (2014) Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome. Blood 124:6, pages 873-881.
Crossref
Crossref
Kanokwan Kulprachakarn, Nittaya Chansiw, Kanjana Pangjit, Chada Phisalaphong, Suthat Fucharoen, Robert C. Hider, Sineenart Santitherakul & Somdet Srichairatanakool. (2014) Iron-chelating and anti-lipid peroxidation properties of 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in long-term iron loading ?-thalassemic mice. Asian Pacific Journal of Tropical Biomedicine 4:8, pages 663-668.
Crossref
Crossref
Chiaki Tanaka. (2014) Clinical Pharmacology of Deferasirox. Clinical Pharmacokinetics 53:8, pages 679-694.
Crossref
Crossref
Sally Temraz, Valeria Santini, Khaled Musallam & Ali Taher. (2014) Iron overload and chelation therapy in myelodysplastic syndromes. Critical Reviews in Oncology/Hematology 91:1, pages 64-73.
Crossref
Crossref
June-Won Cheong, Hyeoung-Joon Kim, Kyoo-Hyung Lee, Sung-Soo Yoon, Jae Hoon Lee, Hee-Sook Park, Ho Young Kim, Hyeok Shim, Chu-Myung Seong, Chul Soo Kim, Jooseop Chung, Myung Soo Hyun, Deog-Yeon Jo, Chul Won Jung, Sang Kyun Sohn, Hwi-Joong Yoon, Byung Soo Kim, Young-Don Joo, Chi-Young Park & Yoo Hong Min. (2014) Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia. Transfusion 54:6, pages 1542-1551.
Crossref
Crossref
William E. Winter, Lindsay A. L. Bazydlo & Neil S. Harris. (2014) The Molecular Biology of Human Iron Metabolism. Laboratory Medicine 45:2, pages 92-102.
Crossref
Crossref
M. Baldini, A. Marcon, R. Cassin, F. M. Ulivieri, D. Spinelli, M. D. Cappellini & G. Graziadei. (2014) Beta-Thalassaemia Intermedia: Evaluation of Endocrine and Bone Complications. BioMed Research International 2014, pages 1-5.
Crossref
Crossref
Shahina Daar, Khaled M. Musallam, Anil Pathare & Ali Taher. (2014) Association between cardiac T2* magnetic resonance imaging values and endocrine function tests in patients with ?-thalassemia major. Blood Cells, Molecules, and Diseases 52:1, pages 50-51.
Crossref
Crossref
Brian A. Taylor, Ralf B. Loeffler, Ruitian Song, Mary E. McCarville, Jane S. Hankins & Claudia M. Hillenbrand. (2013)
Automated T
2
* measurements using supplementary field mapping to assess cardiac iron content
. Journal of Magnetic Resonance Imaging 38:2, pages 441-447.
Crossref
Crossref
M. D. Beaton, S. Chakrabarti, M. Levstik, M. Speechley, P. Marotta & P. Adams. (2013)
Phase
II
clinical trial of phlebotomy for non‐alcoholic fatty liver disease
. Alimentary Pharmacology & Therapeutics 37:7, pages 720-729.
Crossref
Crossref
Ngoc Minh Pham, Akiko Nanri, Siyan Yi, Kayo Kurotani, Shamima Akter, Leng Huat Foo, Nobuo Nishi, Masao Sato, Hitomi Hayabuchi & Tetsuya Mizoue. (2013) Serum ferritin is associated with markers of insulin resistance in Japanese men but not in women. Metabolism 62:4, pages 561-567.
Crossref
Crossref
Somdet Srichairatanakool, Kanjana Pangjit, Chada Phisalaphong & Suthat Fucharoen. (2013) Evaluation of a novel oral iron chelator 1-(N-acetyl-6-aminohexyl)-3-hydroxypyridin-4-one (CM1) for treatment of iron overload in mice. Advances in Bioscience and Biotechnology 04:02, pages 153-163.
Crossref
Crossref
Juliano Lara Fernandes. (2012) Iron chelation therapy in the management of transfusion-related cardiac iron overload. Transfusion 52:10, pages 2256-2268.
Crossref
Crossref
Khawla M. Belhoul, Maisam L. Bakir, Mohamed-SalahEldin Saned, Ahmed M. A. Kadhim, Khaled M. Musallam & Ali T. Taher. (2012) Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major. Annals of Hematology 91:7, pages 1107-1114.
Crossref
Crossref
Brian A. Taylor, Ralf B. Loeffler, Ruitian Song, M. Beth McCarville, Jane S. Hankins & Claudia M. Hillenbrand. (2012) Simultaneous field and R?2* mapping to quantify liver iron content using autoregressive moving average modeling. Journal of Magnetic Resonance Imaging 35:5, pages 1125-1132.
Crossref
Crossref
Yusuf Yilmaz, Ebubekir Senates, Talat Ayyildiz, Yasar Colak, Ilyas Tuncer, Ayse Oya Kurdas Ovunc, Enver Dolar & Cem Kalayci. (2011) Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome. European Journal of Clinical Investigation 42:4, pages 411-418.
Crossref
Crossref
A. OSEI‐BIMPONG, R. McLEAN, E. BHONDA & S. M. LEWIS. (2011) The use of the white cell count and haemoglobin in combination as an effective screen to predict the normality of the full blood count. International Journal of Laboratory Hematology 34:1, pages 91-97.
Crossref
Crossref
Rachid Haidar, Hani Mhaidli, Khaled M. Musallam & Ali T. Taher. (2012) The Spine in β-Thalassemia Syndromes. Spine 37:4, pages 334-339.
Crossref
Crossref
Robert E. Fleming & Prem Ponka. (2012) Iron Overload in Human Disease. New England Journal of Medicine 366:4, pages 348-359.
Crossref
Crossref
Yusuf Yilmaz. (2012) Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome?. World Journal of Hepatology 4:12, pages 332.
Crossref
Crossref
Juliano L. Fernandes, Erika Fontana Sampaio, Monica Verissimo, Fabricio B. Pereira, Jose Alvaro da Silva, Gabriel S. de Figueiredo, Jose M. Kalaf & Otavio R. Coelho. (2011) Heart and liver T2* assessment for iron overload using different software programs. European Radiology 21:12, pages 2503-2510.
Crossref
Crossref
G S Abi Saad, K M Musallam & A T Taher. (2011) The surgeon and the patient with β-thalassaemia intermedia. British Journal of Surgery 98:6, pages 751-760.
Crossref
Crossref
Ali T. Taher, Khaled M. Musallam, Maria Domenica Cappellini & David J. Weatherall. (2011) Optimal management of β thalassaemia intermedia. British Journal of Haematology 152:5, pages 512-523.
Crossref
Crossref
Rachid Haidar, Khaled M. Musallam & Ali T. Taher. (2011) Bone disease and skeletal complications in patients with β thalassemia major. Bone 48:3, pages 425-432.
Crossref
Crossref
Claudio Ponticelli, Khaled M. Musallam, Paolo Cianciulli & Maria Domenica Cappellini. (2010) Renal complications in transfusion-dependent beta thalassaemia. Blood Reviews 24:6, pages 239-244.
Crossref
Crossref